14-3-3σ mediates G2-M arrest produced by 5-aza-2'-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells (Q39318121)

11 September 2017

title

14-3-3σ mediates G2-M arrest produced by 5-aza-2'-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells (English)

1 reference

11 September 2017

main subject

endometrial carcinoma

1 reference

1

Michael Steiner

1 reference

11 September 2017

3

Jian-Zhong Tang

1 reference

author name string

Brett Clark

series ordinal

2

1 reference

11 September 2017

Tao Zhu

series ordinal

4

1 reference

11 September 2017

Peter E Lobie

series ordinal

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

5 July 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

127

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

231-240

1 reference

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

The history of cancer epigenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Dephosphorylation of the inhibitory phosphorylation site S287 in Xenopus Cdc25C by protein phosphatase-2A is inhibited by 14-3-3 binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Claspin: timing the cell cycle arrest when the genome is damaged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Sulforhodamine B colorimetric assay for cytotoxicity screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Replication checkpoint enforced by kinases Cds1 and Chk1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

14-3-3 proteins; bringing new definitions to scaffolding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

In vitro transcriptional activation of p21 promoter by p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Roles for negative cell regulator 14-3-3σ in control of MDM2 activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Promoter Hypermethylation as an Epigenetic Component in Type I and Type II Endometrial Cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

DNA demethylation and cancer: therapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

Abrogation of ionizing radiation-induced G2 checkpoint and inhibition of nuclear export by Cryptocarya pyrones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.039

10.1016/J.YGYNO.2012.06.039

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference